No. |
Product Name |
CAS No. |
Spec |
Price |
|
| LN-3225 |
Nigericin Sodium ≥98% |
28643-80-3 |
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
|
|
| LN-3496 |
Nizatidine ≥98% |
76963-41-2 |
|
|
| LN-5210 |
Nociceptin ≥98% |
170713-75-4 |
|
|
| LN-6076 |
N(p-Tosyl)-GPR-pNA ≥95% |
|
|
|
| LO-0978 |
Octaneuropeptide ≥98% |
|
|
|
| LO-0977 |
Octopamine Hydrochloride ≥98% |
770-05-8 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LO-6132 |
Opioid receptor antagonist Ac-RFMWMK-NH2 ≥98% |
|
|
|
| LO-7116 |
Orexin B, human ≥95% |
|
|
|
| LO-6845 |
Orlistat ≥98% |
96829-58-2 |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LO-7377 |
Osthole ≥98% |
484-12-8 |
| 250 mg |
Inquiry |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
|
|
| LO-8503 |
Ovalbumin fragment (323-339) ≥98% |
|
|
|
| LO-8500 |
Ovalbumin fragment (257-264) ≥98% |
|
|
|
| LO-9497 |
Oxytocin ≥95% |
50-56-6 |
| 5 mg |
Inquiry |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
|
|
| LP-0008 |
Pituitary adenylate cyclase-activating peptide (6-38), human, ovine, rat ≥95% |
137061-48-4 |
| 0.5 mg |
Inquiry |
| 1 mg |
Inquiry |
| 2.5 mg |
Inquiry |
|
|
| LP-0351 |
Pancreatic Polypeptide, rat ≥98% |
90419-12-8 |
| 0.5 mg |
Inquiry |
| 1 mg |
Inquiry |
| 2.5 mg |
Inquiry |
|
|
| LP-0353 |
Pancreatic Polypeptide, human ≥98% |
75976-10-2 |
| 0.5 mg |
Inquiry |
| 1 mg |
Inquiry |
| 2.5 mg |
Inquiry |
|
|
| LP-0352 |
Pancreastatin, porcine ≥98% |
|
| 0.5 mg |
Inquiry |
| 1 mg |
Inquiry |
| 2.5 mg |
Inquiry |
|
|
| LP-0269 |
Parathyroid Hormone (1-34), bovine ≥95% |
12583-68-5 |
| 0.5 mg |
Inquiry |
| 1 mg |
Inquiry |
| 2.5 mg |
Inquiry |
|
|
| LP-0370 |
Paromomycin Sulfate ≥98% |
1263-89-4 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
|
|
| LP-1760 |
Peptide T ≥98% |
106362-32-7 |
|
|
